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Background: To compare the value of ultrasonography for diagnosing carpal tunnel syndrome (CTS) in patients
with and without diabetes mellitus (DM).
Methods: Eighty non-DM and 40 DM patients with electromyography-confirmed CTS were assessed and underwent
high-resolution ultrasonography of the wrists. Cross-sectional area (CSA) and flattening ratio (FR) of the median nerve
were measured at the carpal tunnel outlet (D) and wrist crease (W).
Results: The 80 non-DM and 40 DM patients had 81 and 59 CTS-hands, respectively. The CSA_D and CSA_W were
significantly larger in the CTS-hands and DM-CTS-hands compared to the normal control (p < 0.001). However, there is
no difference of CSA_D and CSA_W between DM and non-DM CTS patients. Receiver operating characteristics [ROC]
curve analysis revealed that CSA_W ≥13 mm2 was the most powerful predictor of CTS in DM (area under curve
[AUC] = 0.72; sensitivity 72.9%, specificity 61.9%) and non-DM (AUC = 0.72; sensitivity 78.5%, specificity 53.2%) patients.
The CSA positively correlated with the distal motor latency of the median compound motor action potential (CMAP),
distal sensory latency of the median sensory nerve action potential (SNAP), and latency of the median F wave, but
negatively correlated with the amplitude of the median CMAP, amplitude of the median SNAP, and sensory NCV of the
median nerve. Stepwise logistic regression revealed that CSA_W (OR 1.21, 95% CI 1.07-1.38; p = 0.003) was independently
associated with CTS in DM patients and any 1 mm2 increase in CSA_W increased the rate of CTS by 28%.
Conclusions: The CSA of the median nerve at the outlet and wrist crease are significantly larger in CTS hands in both
DM and non-DM patients compared to normal hands. The CSA of the median nerve by ultrasonography may be a
diagnostic tool for evaluating CTS in DM and non-DM patients.
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Carpal tunnel syndrome (CTS) is the most common
form of entrapment neuropathy and is characterized by
symptoms associated with localized compression of the
median nerve at the wrist [1]. The pathophysiology is* Correspondence: fangoe@adm.cgmh.org.tw; chlu99@ms44.url.com.tw
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reproduction in any medium, provided the ornot fully understood but two mechanisms are specu-
lated. The early stage involves functional abnormalities
due to the compression of the median nerve in the car-
pal tunnel, while the advanced stage involves structural
abnormalities [2]. Diagnosis is based on clinical presen-
tation and confirmed by electrodiagnostic studies [3],
but nerve conduction studies (NCS) alone do not
provide spatial information regarding the nerve or its
attendant abnormalities.
Ultrasonography is a useful non-invasive diagnostic
method for CTS because it is painless, easily accessible,
and preferred by the patients [4,5]. There is considerable. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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median nerve detected by electrodiagnostic tests and
measurement of its cross-sectional area (CSA) by ultra-
sonography [6,7]. Most investigators agree that CSA
measurement of the median nerve at the pisiform bone is
a valid and reliable test for diagnosing CTS [8]. However,
the standard criteria of CTS by ultrasonography are not
well established, especially in diabetic patients suspected
of CTS.
Although diabetes mellitus (DM) is a risk factor for
CTS [9], reports about median nerve CSA measure-
ments between CTS patients with and without DM are
scant. The aim of this study was to evaluate whether or
not ultrasonographic findings of the median nerve is dif-
ferent between DM and non-DM CTS patients. Particu-
larly, this study was made to elucidate the diagnostic
value of ultrasonography and correlate the diagnostic ac-
curacy of ultrasonography with electrodiagnostic results
in both DM and non-DM CTS patients.
Methods
Study participants
Patients with clinically suspicious CTS at the out-patient
clinics of the Department of Neurology of Kaohsiung
Chang Gung Memorial Hospital were evaluated. Eighty
idiopathic CTS (non-DM) and 67 diabetic patients with
clinical suspicion of CTS were initially included. After
27 with diabetic neuropathy were excluded, 40 DM pa-
tients were finally enrolled. The 80 non-DM participants
had 81 hands with clinical symptoms and electrophysio-
logic diagnosis of CTS (“CTS-hands”), while the 40 DM
patients had 59 hands that fulfilled the clinical and electro-
physiologic diagnostic criteria of CTS (“DM-CTS-hands”)
and 21 hands that were asymptomatic (DM-hands). In
cases when both hands were involved, both hands were
used separately for data analysis. Twenty healthy volun-
teers (40 hands) who had no clinical or NCS evidence of
CTS and no other neurologic disorders were enrolled as
normal control (“C-hands”).
The diagnostic criteria of CTS were according to the
American Academy of Neurology, which included clin-
ical history, symptoms, and evidence of slowing of distal
median nerve conduction [3,10]. The clinical diagnosis
of CTS was based on signs and symptoms of median
nerve distribution such as 1) paresthesia, pain, swelling,
weakness, or clumsiness of the hand provoked or wors-
ened by sleep, sustained hand or arm position, or repeti-
tive action of the hand or wrist that is mitigated by a
change in posture or by shaking of the hand; 2) sensory
deficits in the median nerve-innervated regions of the
hand; 3) motor deficit or hypotrophy of the median
nerve-innervated thenar muscles; and 4) positive pro-
vocative clinical tests (positive Phalen’s maneuver and/or
Tinel’s sign). The clinical diagnosis of CTS was madewhen criterion 1 and one or more of criteria 2–4 were
fulfilled [10,11].
Diabetes mellitus (DM) was diagnosed according to
the criteria of the World Health Organization as fol-
lows: 1) fasting plasma glucose >126 mg/dl (7.0 mmol/l)
where fasting was defined as “no caloric intake for at
least 8 hours”; 2) symptoms of hyperglycemia and ran-
dom plasma glucose >200 mg/dl (11.1 mmol/l), where
random was defined as any time of day without re-
gard to time since last meal; or 3) 2-h plasma glu-
cose >200 mg/dl (11.1 mmol/l) during an oral glucose
tolerance test [12].
Exclusion criteria
Diabetic patients with clinical and electrophysiologic
diagnosis of diabetic polyneuropathy were excluded.
Clinical diagnosis was based on the recommendations
of the American Academy of Electrodiagnostic Medi-
cine (AAEM) [13]. An electrodiagnostic abnormality
plus at least one sign and one symptom confirmed the
presence of polyneuropathy. The neuropathic symp-
toms included sensory symptoms (e.g., distal numb-
ness, burning, prickling paresthesia, dysesthesia, and
allodynia) and/or motor symptoms (i.e., decreased sens-
ibility on the distal lower extremity, distal muscle weak-
ness or atrophy). Neuropathic signs included absent or
decreased ankle deep tendon reflex, decreased or absent
distal sensory capacity, distal weakness, and muscle atro-
phy. Abnormal electrodiagnostic studies included a sural
or peroneal and one median or ulnar nerve dysfunction.
However, entrapment lesions were excluded. Patients
with prior surgery for CTS, and those with gout, rheuma-
toid arthritis, or abnormal thyroid function related to
peripheral neuropathy were also excluded.
The hospital’s Institutional Review Committee on
Human Research approved the study protocol and all of
the participants provided informed consent. A neurologist
(Dr. Cheng-Hsien Lu) experienced in NCS interpretation
and another neurologist (Dr. Shu-Fang Chen) experienced
in ultrasound (US) examinations evaluated the study
participants. Both were blind to the status of the patients.
The musculoskeletal US and NCS examinations were done
by standard laboratory methods [14,15].
Electrodiagnostic testing
The NCS was performed on all participants according to
the recommended AAEM protocol using a Nicolet Viking
Select system (Nicolet Biomedical Inc. Madison, USA) [2].
All tests were done under similar temperature conditions
in the same room. Skin temperature was maintained
at ≥32°C. The routine NCS of the upper extremities was
performed on each participant. The latency, amplitude,
distance, and velocity of the median and ulnar motor and
sensory nerves were measured.
Table 1 Baseline characteristics of the study participants
Non-DM DM Control p value
(n = 80) (n = 40) (n = 20)
CTS hands n (%) 81 (50.6%) 59 (73.8%) -
Female n (%) 48 (60%) 24 (60%) 12 (60%) 0.99
Age (y) 59.3 ± 8.6 61.6 ± 8.4 54.8 ± 9.3 0.06
Body height (cm) 157.0 ± 8.0 158.2 ± 8.0 161.4 ± 8.9 0.16
Body weight (Kg) 60.6 ± 8.7 68.8 ± 16.0 62.0 ± 9.1 0.02
Body mass index 24.6 ± 3.1 27.3 ± 5.0 23.8 ± 3.4 0.01
Circumference of the
wrist (mm)
160.7 ± 10.7 168.1 ± 13.7 158.3 ± 9.8 0.03
P value was calculated by one-way ANOVA analysis among the groups.
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techniques of supra-maximal stimulation. The distal
motor nerve latency (DML) was measured with an active
electrode placed over the muscle belly of the abductor
pollicis brevis. The nerve was stimulated using bipolar
stimulation electrodes, with the cathode positioned 2 cm
proximal to the wrist crease. The cathode was placed
closest to the recording electrode. The average anti-
dromic median and ulnar sensory nerve action poten-
tial (SNAP) response over digit 4 was recorded using
ring electrodes.
Comparative tests included median-ulnar sensory con-
duction between the wrist and ring finger, and median
sensory nerve conduction comparison between the wrist
and palm. Electrophysiologic test results considered
supportive of CTS were median nerve distal sensory
latency >3.4 ms; median nerve distal motor latency over
the thenar >4.2 ms [16]; and difference between median
and ulnar nerve distal sensory latencies >0.4 ms [17].
Ultrasonography assessment
Ultrasonography was performed using a scanner with
a 12/5-MHz linear array transducer for carpal tunnel
study (Philips HDI 5000; Philips Medical Systems, Bothell,
WA). During the examination, the patient sat in a com-
fortable position facing the examiner, with the measured
forearm resting on the table, the palm supine, and fin-
gers semi-extended in the neutral position. The trans-
ducer was placed directly on the patient’s skin with gel.
For the longitudinal scan of the median nerve, the probe
was placed at the midline with the center of the probe
at the distal wrist crease. This provided an initial general
overview of the median nerve. For the transverse scan,
the probe was kept directly perpendicular to the long
axis of the median nerve in order to ensure that the
area measured reflected a cross-sectional area (CSA) and
performed to record the CSA (direct tracing with elec-
tronic calipers around the margin of the nerve excluding
the hyper-echoic epineurial rim).
The CSA and flattening ratio (FR, defined as the ra-
tio of the major axis of the median nerve to its minor
axis) were measured at the outlet of the carpal tunnel
(CSA_D and FR_D, respectively) and wrist crease
(CSA_W and FR_W, respectively). The “tunnel inlet”
referred to the level immediately deep to the proximal
edge of the flexor retinaculum. The “tunnel outlet” re-
ferred to the level immediately deep to the distal edge
of the flexor retinaculum.
Statistical analysis
Data were presented as mean ± standard deviation (SD)
and compared among the groups. Continuous variables
between the two groups were performed using the Student
t test. One-way ANOVA analysis followed by Scheffe’spost-hoc comparison was used to calculate the parameters
of ultrasonography and electrodiagnostic testing values,
while chi-square test or Fisher’s exact test were used as
appropriate to compare proportions among the groups.
Spearman’s rank test was used to assess correlations
between quantitative variables without normal distribution.
Receiver operating characteristics (ROC) curve ana-
lysis was used to determine the CSA value most predict-
ive of CTS hands. Stepwise logistic regression analysis
was used to identify independent predictors of ultrasonog-
raphy for CTS, with adjustments made for other potential
confounding factors. Statistical analysis was performed
using the SPSS statistical software for Windows version 13
(SPSS, Inc., Chicago, Ill., USA). A p < 0.05 was considered
statistically significant.Results
Baseline characteristics among the groups
The demographic data of the study participants were
shown in Table 1. The 80 non-DM and 40 DM patients
had 81 and 59 CTS-hands, respectively. Body weight,
body mass index (BMI), and wrist circumference were
significantly higher in the DM patients than in the non-
DM patients and controls (p < 0.05). There was no sig-
nificant difference in terms of age, sex, and body height
among the three groups.Comparison of ultrasonographic parameters among groups
Parameters of ultrasonography among C-hands, CTS-
hands, DM-CTS-hands, and DM-hands were shown in
Table 2. The CSA_D and CSA_W were significantly dif-
ferent among the four groups (p < 0.01). By one-way
ANOVA with Scheffe’s post-hoc comparison, CSA_D
and CSA_W were significantly larger in CTS-hands
and DM-CTS-hands compared to C-hands or DM-hands
(p < 0.01). However, there is no difference of CSA_D and
CSA_W between DM and non-DM CTS patients. The
FR_D and FR_W were not statistically different among
the four groups.
Table 2 Parameters of ultrasonography among the groups
C-hands CTS-hands DM-CTS-hands DM-hands
(n=40) (n=81) (n=59) (n=21) p value
Median nerve
CSA_D (mm2) 12.0±2.9 15.4±3.8 15.4±4.8 13.8±4.4 0.002α
Flattening ratio_D 3.7±0.9 3.6±1.0 3.5±0.7 3.7±1.2 0.39
CSA_W (mm2) 11.8±2.0 15.3±3.7 15.5±4.8 12.2±3.4 <0.001β
Flattening ratio_W 3.0±0.6 3.4±0.8 3.0±0.7 3.3±0.8 0.10
Abbreviations: CSA cross section area, D at outlet of carpal tunnel, W at the wrist crease.
P value was calculated by one-way ANOVA with post-hoc comparison:
α = CTS-hands vs. C-hands, p = 0.007; DM-CTS-hands vs. C-hands, p = 0.012.
β = CTS-hands vs. C-hands, p < 0.001; DM-CTS-hands vs. C-hands, p < 0.001; CTS-hands vs. DM-hands, p = 0.019; DM-CTS-hands vs. DM-hands, p = 0.014.
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between CTS and DM-CTS groups
A summary of electrodiagnostic parameters between
CTS and DM-CTS groups (Table 3) showed significant
differences in terms of amplitude and motor nerve
conduction velocity (NCV) of median compound motor
action potential (CMAP) (p < 0.001). There were also
significant differences in distal sensory latency, ampli-
tude, and sensory NCV (when stimulating the middle
palms [MP] and the wrist [W]) of the median SNAP be-
tween the two groups (p < 0.05). Latency of the median
F wave was significantly longer in DM-CTS-hands com-
pared to CTS-hands (p < 0.01).
The cut-off value CSA for prediction of CTS
The ROC curve analysis (Figure 1) revealed that CSA_D
≥12 mm2 (area under curve [AUC] 0.62; sensitivityTable 3 Parameters of electrodiagnostic testing between
CTS and DM-CTS groups
CTS-hands DM-CTS-hands
(n = 81) (n = 59) p value
Median nerve
DML (ms) 5.2 ± 1.3 5.3 ± 1.2 0.35
CMAP (mV) 8.5 ± 2.8 6.8 ± 2.7 <0.001
MNCV (m/s) 54.6 ± 4.8 49.2 ± 5.5 <0.001
DSL (ms) 3.4 ± 0.7 3.8 ± 1.0 0.014
SNAP (μV) 25.5 ± 15.1 17.3 ± 12.7 0.001
SNCV_MP (m/s) 62.1 ± 10.4 55.9 ± 12.9 0.003
SNCV_W (m/s) 42.1 ± 7.8 38.7 ± 9.1 0.024
SNCV_D (m/s) 20.0 ± 10.2 17.2 ± 5.6 0.116
FW (ms) 27.0 ± 3.5 28.9 ± 3.5 0.003
Abbreviations: NCV nerve conduction velocity, DML distal motor latency of
median CMAP, CMAP amplitude of median CMAP, MNCV motor NCV of median
CMAP, DSL distal sensory latency of median SNAP, SNAP amplitude of median
SNAP, SNCV_MP sensory NCV when stimulating at the middle palms, SNCV_W
sensory NCV when stimulating at the wrist, SNCV_D, velocity difference
(SNCV_MP - SNCV_W) of SNCV, FW median F wave. p value was calculated by
independent t-test between two groups.78.5% and specificity 53.2%) and CSA_W ≥13 mm2
(AUC 0.72; sensitivity 78.5% and specificity 53.2%) were
the most powerful predictors of non-DM CTS-hands.
The ROC curve analysis of DM-CTS-hands (Figure 2)
revealed that CSA_D ≥13 mm2 (AUC 0.72; sensitivity
71.2% and specificity 53.9%) and CSA_W ≥13 mm2
(AUC 0.72; sensitivity 72.9% and specificity 61.9%) were
the most powerful predictors of DM-CTS-hands. The
ROC curve analysis of all CTS-hands (Figure 3) revealed
that CSA_D ≥12 mm2 (AUC 0.69; sensitivity 75.4% and
specificity 50%) and CSA_W ≥13 mm2 (AUC 0.72; sensi-
tivity 73.2% and specificity 55%) were the most powerful
predictors of CTS.
Correlation among glycemic state of the patients, CSA
and NCS parameters
Spearman's non-parametric correlation among CSA and
electrodiagnostic parameters demonstrated positive cor-
relations in terms of CSA_D, CSA_W, distal motor la-
tency of median CMAP, distal sensory latency of median
SNAP, and latency of median F wave (Table 4). On theFigure 1 The ROC curve analysis of CSA_D (black line) and
CSA_W (dot line) for CTS in non-DM patients.
Figure 2 The ROC curve analysis of CSA_D (black line) and
CSA_W (dot line) for CTS in DM patients.
Table 4 Correlation among glycemic state of the patients,
CSA and electrodiagnostic testing of the median nerve
CSA_D CSA_W
Spearman’s r p r p
DML 0.304 <0.001** 0.379 <0.001**
CMAP -0.132 0.043* -0.265 <0.001**
MNCV -0.050 0.447 -0.115 0.077
DSL 0.212 0.001** 0.334 <0.001**
SNAP -0.187 0.005** -0.311 <0.001**
SNCV_MP -0.039 0.557 -0.151 0.023*
SNCV_W -0.213 0.001** -0.366 <0.001**
SNCV_D 0.137 0.039* 0.188 0.004**
FW 0.199 0.004** 0.158 0.022*
HbA1c 0.254 0.063 0.160 0.252
Duration of DM 0.063 0.712 0.032 0.853
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
Abbreviations: CSA_D cross-section area at outlet of carpal tunnel, CSA_W
cross-section area at the wrist crease, NCS nerve conduction study, NCV nerve
conduction velocity, DML distal motor latency of median CMAP, CMAP
amplitude of median CMAP, MNCV motor NCV of median CMAP, DSL distal
sensory latency of median SNAP, SNAP amplitude of median SNAP, SNCV_MP
sensory NCV when stimulating at the middle palms, SNCV_W sensory NCV
when stimulating at the wrist, SNCV_D velocity difference (SNCV_MP - SNCV_W)
of SNCV, FW median F wave.
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the amplitude of the median CMAP, amplitude of the
median SNAP, and sensory NCV of the median nerve. The
HbA1C and duration of DM were not correlated to the
CSA of the median nerve.
Predictive factors for CTS in DM patients
Possible predictive factors of CTS in DM participants were
listed in Table 5. The BMI and CSA_W were significantly
different between CTS hands and non-CTS hands in DM
patients. Variables used in the stepwise logistic regression
model included sex, body weight, BMI, CSA_D and
CSA_W. After analysis, only CSA_W (OR 1.21, 95% CI
1.07-1.38; p = 0.003) was independently associated with
CTS in DM patients, and any 1 mm2 increase in CSA_W
increased the predictive rate of CTS by 28%.Figure 3 The ROC curve analysis of CSA_D (black line) and
CSA_W (dot line) for CTS in all participants.Discussion
The present study has several major findings. First, the
CSA of the median nerve at the outlet and wrist crease
are significantly larger in CTS hands in both DM and
non-DM patients compared to control hands. Second,
the cut-off value of CSA at the wrist for CTS confirm-
ation is more than 13 mm2 in both DM and non-DM
CTS patients. Third, the CSA of the median nerve at theTable 5 Predictive factors for CTS in DM patients
DM-CTS-hands DM-hands p value
(n = 59) (n = 21)
Age (y) 61.6 ± 9.0 61.6 ± 6.5 0.99
Body height (cm) 158.7 ± 7.8 156.7 ± 8.4 0.45
Body weight (kg) 71.6 ± 17.2 61.3 ± 9.4 0.06
Body mass index 28.3 ± 5.5 24.8 ± 1.8 0.04
Circumference of the wrist (mm) 168.9 ± 13.9 166.7 ± 14.4 0.67
Flattening ratio of the wrist 2.0 ± 0.2 2.1 ± 0.2 0.51
Ultrasonography of median nerve
CSA_D (mm2) 15.4 ± 4.8 13.8 ± 4.4 0.20
Flattening ratio_D 3.5 ± 0.7 3.7 ± 1.2 0.48
CSA_W (mm2) 15.5 ± 4.8 12.2 ± 3.4 0.006
Flattening ratio_W 3.0 ± 0.7 3.3 ± 0.8 0.22
Abbreviations: CSA_D cross-sectional area at the outlet of the carpal tunnel,
CSA_W cross-section area at the wrist crease.
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patients and any increase of 1 mm2 in the CSA at the
wrist crease increases the predictive rate by 28%. Lastly,
the CSA of the median nerve positively correlates to the
distal motor latency of the median CMAP, distal sensory
latency of the median SNAP, and latency of the median
F wave. On the other hand, the CSA of the median
nerve negatively correlates to the amplitude of the me-
dian CMAP, amplitude of the median SNAP, and sensory
NCV of the median nerve.
Significant differences in CSA measurements of the
median nerve between CTS patients and asymptom-
atic controls have been shown in previous studies
[4,14], as well as in the present study. To date, this is
the first study to evaluate the value of ultrasonog-
raphy between DM and non-DM patients with clinical
and electrodiagnostic-confirmed CTS. The CSA of the
median nerve is larger in both DM CTS and non-DM
CTS groups compared to those without CTS. How-
ever, there is no difference in the CSA of the median
nerve at the wrist crease or tunnel outlet between
DM and non-DM CTS patients.
Several studies have explained the phenomenon of
local enlargement of the median nerve in CTS, including
nerve constriction at the site of the entrapment with
proximal swelling [18], and the presence of Renaut bod-
ies [19]. The biological response to compression seems
to be a cascade composed of endoneurial edema, demye-
lination, inflammation, distal axonal degeneration, fibro-
sis, growth of new axons, re-myelination, and thickening
of the perineurium and endothelium [20,21]. A recent
study has demonstrated focal enlargement of median
nerve CSAs in diabetic patients, especially at the level of
the inlet. Other additional factors may contribute to the
phenomenon, including a reduction in myelinated nerve
fibers and capillary density that may predispose DM
patients to develop CTS [22], and the polyol pathway,
glycation and pro-inflammatory reactions that are
known to contribute to diabetic peripheral nerve injuries
[23]. The reasons why CSAs between DM and non-DM
groups are not significant in the present study may be
that the biological response to compression is a more
important contributing factor than diabetic peripheral
nerve injuries.
Previous reports show that increased CSA of the me-
dian nerve is the most predictive parameter for non-DM
CTS [24]. The reported critical values for CSA vary be-
tween 9 and 15 mm2 in the non-DM group. The cause
of this variability may be the differences in study design,
race, grading severity, and measurement techniques
[7,25-29]. However, most of these studies exclude DM
patients to eliminate possible confounding factors of dia-
betic peripheral neuropathy (DPN) in diagnosing CTS.
A previous study has demonstrated that the CSA of themedian nerve in the carpal tunnel of DPN patients is
greater than that of non-DPN patients [30]. However,
their study did not exclude asymptomatic CTS in dia-
betic patients.
The present study excluded diabetic patients with
DPN (e.g. polyneuropathy or mononeuropathy multi-
plex) by NCS and clinical presentations in order to focus
on the entrapment effects of CTS. The cut-off value of
CSA at the wrist crease for CTS confirmation is more
than 13 mm2 in both DM and non-DM CTS patients.
There is no statistical difference in the median CSA be-
tween DM CTS and idiopathic CTS patients in this
study. The results suggest that the entrapment factor
may drown out other factors like metabolic and vascular
causes of median nerve enlargement in CTS.
Median nerve swelling as detected by calculating the
CSA reflects the degree of nerve damage expressed by
the clinical picture. The CSA of the median nerve has a
diagnostic value for confirming or excluding carpal tun-
nel syndrome. However, the relationship among the CSA
of the median nerve, severity of nerve conduction study
(NCS), and clinical severity remains controversial [4,29,31].
In this study, the CSA of the median nerve positively corre-
lates with distal motor latency of the median CMAP and
distal sensory latency of the median SNAP. In other words,
suspicious enlargement of the median nerve damages the
myelin and results in the slowing of nerve conduction vel-
ocity. On the other hand, the CSA of the median nerve
negatively correlates with the amplitude of the median
CMAP and median SNAP, suggesting that median nerve
swelling contributes to axonal degeneration of the median
nerve in CTS. Thus, larger CSA points to more median
nerve damage.
Although electrodiagnostic studies are highly spe-
cific, false negativity can be seen in the variable ratio
of 10-20% [25,32]. Nerve conduction studies mainly
involve large nerve fibers and only identify permanent
nerve damage, which is why the NCS is sometimes
negative. Although median nerve function remains in-
tact, the nerve can already be increasing in size at the
carpal tunnel inlet, as shown by ultrasonography. The
consensus of electrodiagnostic study for CTS is not
specific for DM patients [2,16,17]. The diagnostic
criteria are dependent on the distal latency and NCV
of the median nerve as the constellation of axonal de-
generation is manifested in reduced CMAP amplitude
or underestimated SNAP. The results here demon-
strate that the CSA of the median nerve at the wrist
crease is independently associated with CTS in DM
patients and that any 1 mm2 increase in CSA will
increase the predictive rate of CTS by 28%. As such,
ultrasonography may be considered an alternative diag-
nostic modality when NCS results are not confirmatory
in patients suspected of CTS. The combination of NCS
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mellitus more accurately.
This study has several limitations. First, the electro-
diagnostic unit is in a tertiary referral center with various
specialties like general medicine, orthopedics, and neur-
ology, while the study group is limited to patients with
CTS as a primary diagnosis. A selection bias is in-
herent in this type of hospital-based study and the
results may not be applicable to primary care. Sec-
ond, ultrasonography is an operator-dependent test
and appropriate experience is required to ensure
reliability and reproducibility. With two experienced
physicians performing the US examination, this issue
is easily resolved. Third, DM patients with suspected
polyneuropathy or mononeuropathy multiplex by clin-
ical presentation and NCS were excluded, which may
cause potential bias in statistical analysis. Fourth, the
case number is small, with multiple confounding fac-
tors, especially in the DM group. Finally, the associ-
ation between symptom duration and US findings is
an interesting finding. However, symptoms in most
CTS patients here have an insidious onset, the exact
duration of symptoms can not be determined for
correlation with the severity of US data.
Conclusions
In conclusion, the CSA of the median nerve by ultrason-
ography can be a diagnostic modality for evaluating
CTS. Median nerve swelling is detected by calculating
the CSA, which reflects demyelination and axonal
degeneration of the median nerve. The cut-off value of
CSA at the wrist for CTS confirmation is 13 mm2 for
both DM and non-DM patients. The CSA of the median
nerve at the wrist crease is a predictive factor for CTS in
diabetic patients.
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